Impact
The Center for Regenerative Nanomedicine (CRN) is impacting the future of regenerative medicine by training scientists, expanding research and making contributions to the development of new technologies.
Training Scientists
The Center for Regenerative Nanomedicine trains scientists of the future. Working on CRN projects, researchers gain valuable technical skills in materials design and synthesis, nanomaterials characterization, advanced microscopy, in vitro cell culture and in vivo animal studies.
107Young scientists have been or are currently involved in CRN projects
CRN alumni have advanced their careers at academic institutions, medical centers and industrial companies around the world.
Institutions where CRN alumni can be found include:
- Chiang Mai University
- Massachusetts Institute of Technology
- Northwestern University
- Stanford University
- Tokyo Institute of Technology
- University of California at Berkeley
- University of California, Los Angeles
- University of North Carolina at Chapel Hill
- Cedars-Sinai Medical Center
- Rush Medical College
CRN alumni are also advancing research at companies including:
- AbbVie
- Allergan
- Dimension Inx
- Eastman Chemical Company
- Hazel Technologies
- Stryker
Expanding Research
CRN supports cutting-edge scientific research that has contributed to the field of regenerative nanomedicine.
71 publicationsin peer-reviewed journals
$25.6 millionresearch funding leveraged from CRN Catalyst projects
Projects that received seed funding from the CRN have attracted significant external funding. Read our success stories.
Contributing to Technological Developments
CRN funds research with a high potential for translation.
24 Patent filings have resulted from CRN-sponsored research